KORRES GROUP 9M 2014 FINANCIAL RESULTS

9M 2014 Major Highlights Substantial growth in Consolidated Sales: +28%. +21% growth in Operational profitability (Adjusted EBITDA) Strong Operational Cash flow at +3,4mln EUR and further Net Debt reduction. Strong growth in the international markets: 95,4%. Further growth in Greece: +5,1%, coming from the following successful promo actions and the new product launches throughout the first 9 months of 2014: - Hair category: focused in the communication (TV& Print) of the new revolutionary range of hair colorants, Argan Oil Advanced Colorant , the unique technology pigment-lock , locking the color in hair while moisturizing it in depth. -Face/WildRose : launched a new cream CC – Wild Rose Colour Correcting Cream SPF30/ targeted promo actions in pharmacies, offering complete solutions of high quality at reasonable prices. - Body care: in the category of fragrances, presented two new skus, offering in total a collection of 10 fragrances.

Group 9M 2014 Financial Results at a Glance Sales: +28%, €39,4m from €30,9m in 9M 2013. Adjusted EBITDA (excluding the extraordinary restructuring cost impact) : +21,0%, €7,6m from €6.3m in 9M 2013. Reported EBITDA: +33,0 %, €5,3m from € 4,0m in 9M 2013. EAT & MR : -€0,1m vs - € 1,9m in 9M 2013. +28% +25% +21,0%

9M 2014- Market Development

9M 2014 Regional Analysis Greek sales, increased by 5,1%, following the strong performance of its strategic categories and the enhanced promo actions. +95,4% growth in the international markets, mainly coming from the US market where the Group sells directly its products through its new subsidiary as well as the good performance of the key markets in Europe. In particular, Germany, UK, France, Spain, Scandinavia and Russia presented an average sales growth of 36% vs 9M 2013. +95,4% 9M2014 9M 2013 9M 2014 9M 2013

9M 2014- BU Development

9M 2014 Sales Growth by BU Face & Color products. +27,8% increase, mainly coming from the US market and key European markets such as UK, Spain and France. Body products : strong +32,3% growth coming form the strong performance of the category both in Greece and abroad. Particularly, in Greece, core body products presented significant growth 50% due to the successful promo actions and the launch of the new Santorini Vine collection. Significant contribution also from Sun care products and Fragrances. Abroad US, UK , Spain and Germany were the major contributors of the international growth. Hair products: +14,1% increase, coming mainly from the Greek market and following the positive trend of both traditional hair products and colorants. Especially in colorants, we had the launch of the new revolutionary Argan oil advanced colorant. Pharmaceutical & others: +35,1% higher due to the good performance of US market and the strategic agreement with Lufthansa. +27,8% +32,3% +14,1% +35,1%

9M 2014 Gross Profit Analysis Group’s GM% was 59,5% in 9M 2014 from 60,7% in 9M 2013, due to proportionally higher exports sales. GM% in Face & color category remained at the same level of 68,0%. Hair GM% reached 57,0% from 61,0%, coming from the increased promo actions . Body GM% increased at 57,0% from 54,0% in 9M 2013 due to product and country mix. Pharmaceuticals & Others GM% reduction coming from the enhanced promo actions.

Group 9M 2014 Financial Position Highlights In m € 9M 2014 FY 2013 ST Debt 12,0 12,6 LT Debt 20,9 22,0 TOTAL Debt 32,9 34,6 Net Debt 26,0 27,6

Group 9M 2014 Cash Flow Highlights Cash Flow (€ m) 9M 2014 9M 2013 Change (%) Operating Cash Flow 3,4 4,6 -27% Investment Cash Flow -1,8 -2,1 -16% Financing Cash Flow -1,7 -1,5 14% Net Change in Cash -0,1 1,0 -112% Cash and Cash Equivalents, Beginning of the Period 6,9 5,3 31% Cash and Cash Equivalents, End of the Period 6,8 6,3 8%

APPENDIX

P&L STATEMENT (9M 2014 VS 9M 2013) 9M 2014 9M 2013 Change (%) Revenues 39,4 30,9 27,7% Cost of goods sold -16,0 -12,1 31,6% Gross Profit 23,5 18,8 25,1% Gross Margin (%) 59,5% 60,7% -2,0% Operating Expenses -21,8 -18,7 16,5% Adjusted EBITDA (before restructuring cost impact) 7,6 6,3 21,0% Adjusted EBITDA Margin (%) 19% 20% -5,2% Reported EBITDA 5,4 4,0 34,9% EBITDA Margin (%) 13,8% 13,1% 5,6% Depreciation and Amortization 3,7 -7,5% EBIT 1,7 0,041 3898,5% Operating Margin (%) 4,2% 0,1% 3032,4% Net Interest Income/Expenses -1,7 -1,8 -4,6% Investment Results -0,05 -0,1 -28,3% Earnings Before Tax (EBT) -1,9 -92,5% EBT Margin (%) -0,4% -6,0% -94,1% Tax -0,3 14,7% Earnings After Taxes (EAT) -0,4 -2,1 -79,3% Minority rights -0,2 74,6% Reported Earnings after Taxes and Minorities (EATAM) -93,1% Reported EATAM Margin (%) -0,3% -6,3% -94,6%

BALANCE SHEET ( 9M2014 VS 2013) 9M 2014 FY 2013 Change (%) Assets   Property, Plant and Equipment 16,6 17,6 -5,8% Intangible Assets 6,9 7,7 -10,6% Investments in Subsidiary & Associated Companies 0,4 -11,8% Financial Assets for Sale 0,3 -3,4% Goodwill 8,1 0,0% Deferred Taxation 0,8 133,6% Other Long-Term Receivables 0,1 -7,2% Total Non-Current Assets 33,3 34,7 -4,1% Inventories 15,8 16,7 -5,4% Customers and Other Receivables 16,8 11,0 52,6% Cash and Cash Equivalent 6,8 5,3 28,3% Total Current Assets 39,4 13,7% Total Assets 72,7 69,4 4,8% Shareholder’s Equity and Liabilities Share Capital Paid up Capital Reserves 0,7 -1,2% Retained Earnings -3,8 0,4% Shareholders’ Equity to the Shareholders of the Company 19,0 -0,1% Minority Interest -0,94 -0,63 48,3% Total Shareholders Equity 18,0 18,3 -1,8% Long-term Loans 20,9 22,0 -5,1% Deferred Tax Liabilities 0,0 1,1 -96,2% Retirement Benefit Obligations 0,6 14,2% Total Long-Term Liabilities 21,6 23,6 -8,7% Suppliers and Other Liabilities 18,9 13,7 38,5% Short-Term Loans 12,0 12,6 -4,6% Current Tax Liabilities 2,2 92,1% Total Current Liabilities 33,1 27,4 20,9% Total Liabilities 54,7 51,0 7,2% Total Shareholder’s Equity and Liabilities

THANK U